Skip to content

NUTRA PHARMA CORP.: filings

Every NUTRA PHARMA CORP. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-19fiscal Q2 2026371020001493152-26-039166
10-Q2026-05-29fiscal Q1 202636710001493152-26-026420
10-K2026-05-20fiscal FY 202540760001493152-26-024641
10-Q2026-04-06fiscal Q3 2025401100001493152-26-015334
10-Q2026-03-25fiscal Q2 2025411120001493152-26-012625
10-Q2026-03-11fiscal Q1 202539770001493152-26-009667
10-K2026-02-17fiscal FY 202441810001493152-26-007044
10-Q2026-01-02fiscal Q3 2024401120001493152-26-000067
10-Q2025-12-23fiscal Q2 2024411130001493152-25-028946
10-Q2025-12-17fiscal Q1 202441820001493152-25-028202
10-K2025-11-24fiscal FY 202343840001493152-25-024800
10-Q2025-10-28fiscal Q3 2023441170001493152-25-019875
10-Q2025-10-23fiscal Q2 2023441180001493152-25-019037
10-Q2025-10-16fiscal Q1 202343850001493152-25-018328
10-K2025-09-03fiscal FY 202242830001641172-25-026446
10-Q2022-11-21fiscal Q3 2022391070001493152-22-033171
10-Q2022-08-22fiscal Q2 2022381060001493152-22-023751
10-Q2022-05-20fiscal Q1 202238770001493152-22-014637
10-K2022-04-15fiscal FY 202135710001493152-22-010035
10-Q2021-11-10fiscal Q3 2021381020001493152-21-027793
10-Q2021-09-24fiscal Q2 202137990001493152-21-023540
10-Q2021-09-17fiscal Q1 202138750001493152-21-022993
10-K2021-09-08fiscal FY 202038730001493152-21-022204
10-Q2021-08-12fiscal Q3 202037990001493152-21-019469
10-Q2021-08-05fiscal Q2 2020371000001493152-21-018715
10-Q2021-07-23fiscal Q1 202036730001493152-21-017638
10-K2021-07-01fiscal FY 201934700001493152-21-015860
10-Q2021-05-14fiscal Q3 201934910001493152-21-011455
10-Q2021-05-07fiscal Q2 201932820001398432-21-000040
10-Q2021-04-05fiscal Q1 201932640001398432-21-000029
10-K2021-02-05fiscal FY 201832620001398432-21-000007
10-Q2018-11-19fiscal Q3 201831790001398432-18-000131
10-Q2018-08-17fiscal Q2 201830780001398432-18-000103
10-Q2018-05-21fiscal Q1 201830600001398432-18-000069
10-K2018-04-17fiscal FY 201735700001398432-18-000049
10-Q2017-11-20fiscal Q3 201733790001398432-17-000163
10-Q2017-08-14fiscal Q2 201732770001398432-17-000126
10-Q2017-05-17fiscal Q1 201732640001398432-17-000086
10-K2017-04-17fiscal FY 201634690001398432-17-000073
10-Q2016-11-22fiscal Q3 201633800001398432-16-000772
10-Q2016-08-22fiscal Q2 201634800001398432-16-000724
10-Q2016-06-21fiscal Q1 201636690001398432-16-000672
10-K2016-04-14fiscal FY 201538770001398432-16-000597
10-Q2015-11-23fiscal Q3 201536850001398432-15-000411
10-Q2015-08-18fiscal Q2 201536830001398432-15-000317
10-Q2015-05-19fiscal Q1 201536680001398432-15-000257
10-K2015-04-13fiscal FY 201437730001398432-15-000168
10-Q2014-11-14fiscal Q3 201436840001398432-14-000409
10-Q2014-08-14fiscal Q2 201431760001398432-14-000313
10-Q2014-05-20fiscal Q1 201426520001552781-14-000479
10-K2014-03-31fiscal FY 201329600001144204-14-019555
10-Q2013-11-19fiscal Q3 201329770001144204-13-063102
10-Q2013-08-19fiscal Q2 201328750001144204-13-046848
10-Q2013-05-20fiscal Q1 201328660001144204-13-030545
10-K2013-04-16fiscal FY 201231660001144204-13-022247
10-Q/A2012-12-12fiscal Q3 201223620001144204-12-067558
10-Q/A2012-12-07fiscal Q2 201223620001144204-12-066928
10-Q/A2012-11-28fiscal Q1 201223480001144204-12-065280
10-K/A2012-11-15fiscal FY 201128580001144204-12-063254
10-Q2011-11-15fiscal Q3 201124640001144204-11-064907
10-Q2011-08-15fiscal Q2 201124640001144204-11-047222

Inspect the source

Entity
NUTRA PHARMA CORP. / CIK 0001119643
Captured
2026-09-20T05:24:45.365Z
SEC response SHA-256
a9ccf17d1b07544de23a6dd72641e83d2b0b8f34b5c47b58fd5a236f1c887339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001119643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))